Skip to search formSkip to main content

FC-1157a

Known as: FC 1157a, FC1157a 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
The anti-estrogen toremifen-Fc-1157a or 4-chloro-1,2-diphenyl-1-[4-[2(N,N-dimethylamino)ethoxy]-phenyl]-1- butene is now used for… Expand
Is this relevant?
1990
1990
Nine patients with measurable lesions of locally advanced or recurrent breast cancer have been treated with toremifene 200 mg… Expand
Is this relevant?
Review
1990
Review
1990
New compounds were synthesized with the aim to develop new anti-estrogenic antitumor drugs. The biological properties of the… Expand
Is this relevant?
Highly Cited
1986
Highly Cited
1986
SummaryThe basic pharmacological and biochemical properties of a new antiestrogen, Fc-1157a, are described. Fc-1157a is bound… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1986
1986
SummaryThe antitumor effects of a new antiestrogen, Fc-1157a1 have been studied in vitro and in vivo. In vitro the effect of Fc… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
1985
1985
We studied the in vitro effects of two anti-oestrogens (tamoxifen and FC-1157a) on human lymphocyte functions in pokeweed mitogen… Expand
Is this relevant?
1985
1985
The effect of human interferons alpha and gamma alone and in combination with a novel antiestrogen toremifene were studied in… Expand
Is this relevant?